Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,318 | -11,860 | -10,000 | -9,948 | -13,640 |
| Depreciation Amortization | 348 | 154 | 107 | 81 | 48 |
| Accounts receivable | -177 | 33 | 15 | -48 | N/A |
| Accounts payable and accrued liabilities | 67 | -247 | 515 | -350 | -270 |
| Other Working Capital | -955 | -2,429 | 1,214 | -513 | -430 |
| Other Operating Activity | 2,022 | 1,461 | 629 | 2,176 | 10,867 |
| Operating Cash Flow | $-11,012 | $-12,887 | $-7,520 | $-8,603 | $-3,425 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 3,027 | -2,970 | N/A | N/A |
| PPE Investments | -120 | -377 | -275 | -67 | -122 |
| Investing Cash Flow | $-120 | $2,650 | $-3,245 | $-67 | $-122 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 8,358 |
| Common Stock Issued | 7,684 | 8,590 | 12,023 | 11,587 | 8 |
| Common Stock Repurchased | -81 | -119 | N/A | N/A | N/A |
| Other Financing Activity | -333 | -1,072 | 0 | -52 | -1,042 |
| Financing Cash Flow | $7,270 | $7,399 | $12,023 | $11,535 | $7,323 |
| Beginning Cash Position | 5,323 | 8,160 | 6,901 | 4,036 | 261 |
| End Cash Position | 1,460 | 5,323 | 8,160 | 6,901 | 4,036 |
| Net Cash Flow | $-3,863 | $-2,838 | $1,259 | $2,865 | $3,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,012 | -12,887 | -7,520 | -8,603 | -3,425 |
| Capital Expenditure | -120 | -384 | -275 | -67 | -122 |
| Free Cash Flow | -11,132 | -13,271 | -7,795 | -8,670 | -3,548 |